Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study

Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study

Currently, targeted alpha therapy is one of the most investigated topics in radiopharmaceutical cancer management. Especially, the alpha emitter <sup>225</sup>Ac has excellent nuclear properties and is gaining increasing popularity for the treatment of various tumor entities. We herein r...

Full description

Bibliographic Details
Main Authors: Falco Reissig, David Bauer, Kristof Zarschler, Zbynek Novy, Katerina Bendova, Marie-Charlotte Ludik, Klaus Kopka, Hans-Jürgen Pietzsch, Milos Petrik, Constantin Mamat
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
actinium-225
PSMA
theranostics
targeted alpha therapy
click chemistry
Online Access:https://www.mdpi.com/2072-6694/13/8/1974

Internet

https://www.mdpi.com/2072-6694/13/8/1974

Similar Items